Zobrazeno 1 - 10
of 36
pro vyhledávání: '"Ahmed R"'
Publikováno v:
Surgical Endoscopy
Background After the declaration of COVID-19 as a pandemic last March 2020, several adjustments in surgical services were implemented. Plans are now being formulated for restarting bariatric surgery. The aim of this survey is to capture the practice
Autor:
Krishna Moorthy, Sanjay Purkayastha, Saira Hameed, Alexander D. Miras, Ahmed R. Ahmed, Trisha Tan, Sherif Hakky, Patricia Ortega, Sami Mansour, Osama Moussa, Jonathan Cousins, Harvinder Chahal, Christos Tsironis, Sara Flod
Publikováno v:
Obesity Surgery
Autor:
Susan J. Copley, Athol U. Wells, Jonathan Cousins, Anthony Edey, Neil D. Soneji, Lalani Carlton Jones, Ahmed R. Ahmed
Publikováno v:
Radiology. 294:669-675
Background There is significant pulmonary functional deficit related to obesity, but no prospective CT studies have evaluated the effects of obesity on the lungs and trachea. Purpose To evaluate lung parenchymal and tracheal CT morphology before and
Autor:
Jia V. Li, James Minnion, Kleopatra Alexiadou, George Tharakan, Ahmed R. Ahmed, Stephen R. Bloom, Matthew R. Lewis, Preeshila Behary, Sanjay Purkayastha, Ben Jones, Tricia Tan, Caroline Sands
Publikováno v:
e782
e767
The Journal of Clinical Endocrinology and Metabolism
e767
The Journal of Clinical Endocrinology and Metabolism
Context The gut-derived peptide hormones glucagon-like peptide-1 (GLP-1), oxyntomodulin (OXM), and peptide YY (PYY) are regulators of energy intake and glucose homeostasis and are thought to contribute to the glucose-lowering effects of bariatric sur
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::79846c6772014111d5d75a84f56ac136
http://hdl.handle.net/10044/1/91275
http://hdl.handle.net/10044/1/91275
Autor:
Madhawi Aldhwayan, Stephen R. Bloom, Werd Al-Najim, Belén Pérez-Pevida, Aviva Petrie, Omar A. Khan, Ahmed R. Ahmed, Veronica Greener, Barbara McGowan, Alexander D. Miras, Harvinder Chahal, Samantha Scholtz, Tricia Tan, Anna Kamocka, Emma Rose McGlone, Rachel L. Batterham
Publikováno v:
The Lancet Diabetes & Endocrinology. 7:549-559
Summary Background Many patients with type 2 diabetes do not achieve sustained diabetes remission after metabolic (bariatric) surgery for the treatment of obesity. Liraglutide, a glucagon-like peptide-1 analogue, improves glycaemic control and reduce
Publikováno v:
Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery. 18(1)
Background Surgical quality assurance methods aim to ensure standardization and high quality of surgical techniques within multicenter randomized controlled trials (RCTs), thereby diminishing the heterogeneity of surgery and reducing biases due to su
Autor:
Sherif Hakky, Shamsi El-Hassani, A Sudlow, Dimitri J Pournaras, Spyros Panagiotopoulos, Alpesh Patel, Saira Hameed, Harvinder Chahal, C. W. le Roux, Ahmed R. Ahmed, S Samarasinghe, Christos Tsironis, Krishna Moorthy, Alexander D. Miras, Georgios K Dimitriadis, S Aylwin, Sanjay Purkayastha
Publikováno v:
The British Journal of Surgery
e180
e179
e180
e179
Autor:
Ahmed R. Ahmed, Julia Kenkre, Tricia Tan, Sanjay Purkayastha, Stephen R. Bloom, A Toby Prevost, Khalefah Malallah, Alexandra I. F. Blakemore
Publikováno v:
BMJ Open
BMJ Open, Vol 11, Iss 2 (2021)
BMJ Open, Vol 11, Iss 2 (2021)
IntroductionType 2 diabetes mellitus (T2DM) and obesity are pandemic diseases that lead to a great deal of morbidity and mortality. The most effective treatment for obesity and T2DM is bariatric or metabolic surgery; it can lead to long-term diabetes
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9abc9d30f398fec849d01c62865da08d
http://hdl.handle.net/10044/1/87213
http://hdl.handle.net/10044/1/87213
Autor:
Peter Walton, James Byrne, Kamal Mahawar, Rachel L. Batterham, Gul Bano, David Kerrigan, Marcus Reddy, Robin Kinsman, Vinod Menon, Howard Thom, Ahmed R. Ahmed, Peter K. Small, Chandra V.N. Cheruvu, Prem Chana, C Borg, James Hopkins, Vladica M. Veličković, Catherine Leonard, Emma Rose McGlone, Omar A. Khan, Richard Welbourn, Carel W. le Roux, Bruno Sgromo, Shaw Somers, Iain M Carey
Publikováno v:
PLoS Medicine
PLoS Medicine, Vol 17, Iss 12, p e1003228 (2020)
PLoS Medicine, Vol 17, Iss 12, p e1003228 (2020)
Background Although bariatric surgery is well established as an effective treatment for patients with obesity and type 2 diabetes mellitus (T2DM), there exists reluctance to increase its availability for patients with severe T2DM. The aims of this st
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b7508f5b1fcbe1677ee2f794cfa2946f
https://openaccess.sgul.ac.uk/id/eprint/112686/3/journal.pmed.1003228.pdf
https://openaccess.sgul.ac.uk/id/eprint/112686/3/journal.pmed.1003228.pdf
Publikováno v:
PLoS Medicine, Vol 17, Iss 7, p e1003206 (2020)
PLoS Medicine
PLoS Medicine
Background Previous clinical trials and institutional studies have demonstrated that surgery for the treatment of obesity (termed bariatric or metabolic surgery) reduces all-cause mortality and the development of obesity-related diseases such as type
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7f7ab8017a71d801c79541c39c2c17ee
http://hdl.handle.net/10044/1/81823
http://hdl.handle.net/10044/1/81823